lycorine has been researched along with Osteoporosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Fan, SW; Hu, ZJ; Huang, KM; Jin, G; Ma, JJ; Ma, Y; Qin, A; Tang, XZ; Wang, JY; Wang, Q; Zhou, ZJ | 1 |
1 other study(ies) available for lycorine and Osteoporosis
Article | Year |
---|---|
Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo.
Topics: Amaryllidaceae Alkaloids; Animals; Bone Density Conservation Agents; Bone Marrow; Cell Differentiation; Cell Survival; Disease Models, Animal; Female; Gene Expression Regulation; Macrophages; Male; MAP Kinase Kinase 4; MAP Kinase Kinase 7; Mice; Mice, Inbred C57BL; Mice, Transgenic; Osteoclasts; Osteogenesis; Osteolysis; Osteoporosis; Ovariectomy; Phenanthridines; Primary Cell Culture; RANK Ligand; Signal Transduction; Titanium | 2015 |